Snap Chart

Weight-loss Drugs Aren't Just Changing Waistlines

A Bain survey shows GLP-1 drugs, like those known as Ozempic or Wegovy, lead to significant changes in consumer behavior that often persist even after consumers stop taking them.

Di Emily Miller, Sarah Hershey, e Samantha Gorang

Snap Chart

Weight-loss Drugs Aren't Just Changing Waistlines
en

About the Research

Data powered by Dynata, a leading global first-party data and insights platform.

Industry Expertise

Explore Bain's expertise in Consumer Products and learn how we can help your company.

LEARN MORE
First published in dicembre 2024
Tags

Come abbiamo aiutato i nostri clienti

A Food Company’s Bold Play to Restore Margin and Growth

Leggi un caso di studio

Drinking in digital: A leading beverage company stirs a profit from digital strategy

Leggi un caso di studio

Strategia Focus on core delivers growth for retailer

Leggi un caso di studio

Vuoi continuare la conversazione?

Aiutiamo i leader globali e le loro aziende ad affrontare problemi e a cogliere le opportunità. Sosteniamo cambiamenti e otteniamo risultati duraturi.

Contatta Bain

Come posso aiutarti?

Guarda tutti gli uffici